Welgene Biotech Co (6661.TWO) Stock Price

Welgene Biotech Co Price

CLOSED
17.20
​
Market closed

Revenue has compounded at 3.0% per year over the past 11 years to 375.94 M TWD. Earnings per share have declined at 22.2% per year over the last 11 years. Welgene Biotech Co's net margin stands at 0.4%, down from 4.4% several years earlier. Welgene Biotech Co currently offers a dividend yield of about 1.05%.

Welgene Biotech Co stock price

Access this data via the Eulerpool API

Welgene Biotech Co business model & stock analysis

Welgene Biotech Co., Ltd. engages in the provision of biotechnology services including genetic testing, molecular diagnosis, and bioinformatics support for universities, hospitals, pharmaceutical companies, and others. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-10-23. The firm focuses on deoxyribonucleic acid (DNA) microarray, Next Generation Sequencing and real-time quantitative polymerase chain reaction (PCR) and other testing technologies, which used in school research units, hospitals and biotech companies. The firm is also engaged in the trading of medical equipment. The firm mainly operates in two business segments, including Biotechnology Testing segment and Equipment Trading segment. The firm mainly operates in Taiwan market.

Frequently asked questions about Welgene Biotech Co

Converted at the current exchange rate, the Welgene Biotech Co share trades at 0.48 EUR (17.20 TWD).

The revenue cannot currently be calculated for Welgene Biotech Co.

The profit cannot currently be calculated for Welgene Biotech Co.

The P/E ratio cannot be calculated for Welgene Biotech Co at the moment.

The P/S cannot be calculated for Welgene Biotech Co currently.

The Eulerpool Quality Score for Welgene Biotech Co is 2/10.

The ISIN of Welgene Biotech Co is TW0006661002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Welgene Biotech Co is 6661.TWO. The ticker symbol is used to trade Welgene Biotech Co shares on the stock exchange.

Fair ValueTerminal
16.34 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Oct 23, 2017
ISIN
TW0006661002
Cusip
Y953A4103
Market capitalization
400.76 M TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
5,572.28
P/B Ratio
1.42
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.31 %
Dividend
Dividend yield
0.00 %
Payout Ratio
118.17 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Oct 9, 2026, 11:34 PM

Welgene Biotech Co Peer Group

Welgene Biotech Co FIGI

6661:TT (Taipei Stock Exchange) · BBG00HZ1XRP8